MCDERMOTT+ LLC

Lobbying for 340B HEALTH · Association focusing on the 340B drug pricing program

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Jul 7, 2025

Lobbying activity 2

Health Issues

Issues relating to the 340B Drug Pricing Program.

Medicare/Medicaid

Issues relating to the 340B Drug Pricing Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.